Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
Davide Antonio Mei, Medical Doctor – PhD in Clinical and Experimental Medicine at University of Modena and Reggio Emilia, shared a post on Linkedin about a recent article he and his colleagues co-authored, published in EP Europace, adding:
“Excited to share our new Controversy, now out in Europace!
Anticoagulants need to be maintained after catheter ablation of atrial fibrillation in patients at risk of stroke – Pro and Contra.
We discuss a highly topical question in AF management: should oral anticoagulation be continued or discontinued after successful catheter ablation?
We explore the arguments for and against stopping anticoagulation, considering the latest evidence from randomized clinical trials, observational studies, and meta-analyses.
An important ongoing debate at the intersection of rhythm control, stroke prevention, and bleeding risk.”
Title: Controversy: Anticoagulants need to be maintained after catheter ablation of atrial fibrillation in patients at risk of stroke—Pro and Contra
Authors: Giuseppe Boriani, Serge Boveda, Davide A Mei, Laurent Fauchier, Jacopo F Imberti, Rui Providencia, Gregory Y H Lip

Stay updated with Hemostatis Today.
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments
-
Nov 16, 2026, 12:44Stefan Prendić: How Intronic Variants Affect Rh Blood Group Antigen Expression
-
Nov 16, 2026, 12:26Samwel Mikaye: Understanding Warfarin and Its Clinical Management